Recent news on

UPDATE 2-US FDA clears J&J, Millennium cancer drug combo  -  May 18, 2007
ReutersFoster added that the new combination use for Doxil, an injectable form of doxorubicin hydrochloride, would add an important therapeutic option for cancer

Newly-Published Study Shows CAELYX(R) Plus Carboplatin to Be ...  -  Feb 16, 2007
netPR.pl (komunikaty prasowe),CAELYX is a long-circulating pegylated liposomal formulation of doxorubicin hydrochloride, a widely used cytotoxic agent. Cytotoxic agents are designed to

Newly-Published Study Shows CAELYX(R) Plus Carboplatin to Be ...  -  Feb 16, 2007
Earthtimes.org...amulticentre phase II clinical trial that found treatment with CAELYX(R)(pegylated liposomal doxorubicin hydrochloride), in combination withcarboplatin,

Pharmion Acquires Cabrellis Pharmaceuticals, Gains Rights to ...  -  Nov 15, 2006
Earthtimes.org...(8) US Prescribing Information, Adriamycin(R), doxorubicin hydrochloride, page 1, warning 2, October 2000. This press release contains forward-looking



Interlocutory Injunctions for Pharmaceutical Patent Infringement  Mar 15, 2006
Under that licence, Pfizer manufactures and sells ready-to-use solutions of doxorubicin hydrochloride and epirubicin hydrochloride. ... - Mondaq News Alerts

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional